Collectively, our findings suggest that NRG1-AdMSCs transplantation after ischemic stroke can activate MAPK and Akt pathways, possibly through the upregulation of the NRG1 receptor, ErbB4. The gene discussed is ERBB4; the disease is ischemic stroke.